In the article titled “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” [1], with regard to the FRAX® tool, it has been reported that “Among the different tools to assess fracture risk, the WHO fracture risk assessment (FRAX) is a computer based algorithm (http://www.shef.ac.uk/FRAX/) primarily intended for use in primary care [56, 57].” We point out that the metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. Additionally, the name of the fourth author was given incorrectly as Morabito Nunziata. The author's name should have been written as Nunziata Morabito. The revised authors' list is shown above.
Corrigendum | Open Access
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences”
Received23 May 2017
Accepted31 May 2017
Published16 Jul 2017
References
G. T. Russo, A. Giandalia, E. L. Romeo et al., “Fracture risk in type 2 diabetes: current perspectives and gender differences,” International Journal of Endocrinology, vol. 2016, Article ID 1615735, 11 pages, 2016.
View at: Publisher Site | Google ScholarN. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, no. 12, p. 862, 2016.
View at: Publisher Site | Google Scholar
Copyright
Copyright © 2017 Giuseppina T. Russo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.